Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2003
07/31/2003WO2003062400A2 Fiber shaft modifications for efficient targeting
07/31/2003WO2003062395A2 Predictor sets for tyrosine kinase pathways
07/31/2003WO2003062394A2 Methods and compositions for rna interference
07/31/2003WO2003062384A2 Stem cell maturation for all tissue types
07/31/2003WO2003062382A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals
07/31/2003WO2003062381A2 Multiply-substituted protease variants
07/31/2003WO2003062380A2 Multiply-substituted protease variants
07/31/2003WO2003062370A2 Multimeric proteins and methods of making and using same
07/31/2003WO2003062369A2 Expansion of renewable stem cell populations
07/31/2003WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
07/31/2003WO2003062276A2 Multimers of receptor-binding ligands
07/31/2003WO2003062275A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003WO2003062274A1 Novel proteins and dnas thereof
07/31/2003WO2003062271A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
07/31/2003WO2003062270A2 Fluorescent protein from aequorea coerulscens and uses therof
07/31/2003WO2003062264A2 Functional ligand display
07/31/2003WO2003062262A2 Modulation of heat-shock-protein-based immunotherapies
07/31/2003WO2003061690A1 Stimulation of bone growth and cartilage formation with thrombing peptide derivatives
07/31/2003WO2003061683A1 Peptides for enhancing resistance to microbial infections
07/31/2003WO2003061595A2 Antibodies against and compositions containing new amphetamine derivatives
07/31/2003WO2003061591A2 Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis
07/31/2003WO2003061582A2 Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach
07/31/2003WO2003061580A2 Alteration of rab38 function to modulate mammalian pigmentation
07/31/2003WO2003061392A1 Pure populations of astrocyte restricted precursor cells and methods for isolation and use thereof
07/31/2003WO2003061365A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
07/31/2003WO2003061363A2 Mutations caused by activation-induced cytidine deaminase
07/31/2003WO2003037253A3 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
07/31/2003WO2003035679A3 Molecules
07/31/2003WO2003031571A3 Novel human proteins, polynucleotides encoding them and methods of using the same
07/31/2003WO2003028636A3 Antisense modulation of il-1 receptor-associated kinase-4 expression
07/31/2003WO2003027246A3 Antagonists
07/31/2003WO2003025140A3 Transductin-1 and transductin-2 and applications to hereditary deafness
07/31/2003WO2003016486A3 Bio-synthetic photostimulators and methods of use
07/31/2003WO2003016333A3 Virus coat protein/receptor chimeras and methods of use
07/31/2003WO2003010243A3 Multipotent stem cells from peripheral tissues and uses thereof
07/31/2003WO2003006607A3 Inhibition of apoptosis process and improvement of cell performance
07/31/2003WO2003006499A3 Survivin interacting protein tpr1
07/31/2003WO2003004607A3 Aggrecanase molecules
07/31/2003WO2003000024A3 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
07/31/2003WO2002101005A3 A g-protein coupled receptor and uses therefor
07/31/2003WO2002099042A3 Cads as modifiers of the p53 pathway and methods of use
07/31/2003WO2002086123A3 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
07/31/2003WO2002083849A9 Vascular endothelial growth factor 2
07/31/2003WO2002058716A3 Treatment of inflammatory bowel disease using growth factors
07/31/2003WO2002039885A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/31/2003WO2002029038A3 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
07/31/2003WO2002027005A3 Enhanced transfection system
07/31/2003WO2002024909A3 Receptor nucleic acids and polypeptides
07/31/2003WO2002024897A3 Conditionally replicating viral vectors and their use
07/31/2003WO2002020847A3 Gene and sequence variation associated with lipid disorder
07/31/2003WO2002018548A3 Tyrosine hydroxylase 5' control elements and uses thereof
07/31/2003WO2002012286A3 Stress proteins and peptides and methods of use thereof
07/31/2003WO2002004489A3 Polymorphic kinase anchor proteins and nucleic acids encoding the same
07/31/2003WO2002004010A3 Inhibition of tumor growth by a nematode anticoagulant protein
07/31/2003WO2001096870A3 Immunoassays for anti-hcv antibodies
07/31/2003US20030145352 Nucleic acid molecules from rice and their use for the production of modified starch
07/31/2003US20030145348 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target
07/31/2003US20030145347 Grain processing method and transgenic plants useful therein
07/31/2003US20030145341 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression
07/31/2003US20030144497 Novel human transferase proteins and polynucleotides encoding the same
07/31/2003US20030144495 Drosophila recombination-associated protein and methods for use
07/31/2003US20030144492 Anticancer agents; central nervous system disorders; antiinflammatory agents
07/31/2003US20030144486 Monoclonal human natural antibodies
07/31/2003US20030144485 Monoclonal human natural antibodies
07/31/2003US20030144482 Diagnosis of skin cancer; vaccine
07/31/2003US20030144480 Genetic engineering; medical diagnosis
07/31/2003US20030144476 Genetic engineered polypeptide; medical diagnosis
07/31/2003US20030144241 Antisense modulation of Smad6 expression
07/31/2003US20030144239 Expression system
07/31/2003US20030144232 Expression system
07/31/2003US20030144224 Antisense modulation of B-cell associated protein expression
07/31/2003US20030144209 Bone anabolic agents for the treatment of bone disease
07/31/2003US20030144200 Novel forms of the angiogenic factor vascular endothelial cell growth factor: VEGF
07/31/2003US20030144197 Autologous growth factor cocktail composition, method of production and use
07/31/2003US20030144192 Crystal proteins which exhibit insecticidal activity against coleopteran insects including red flour beetle larvae (Tribolium castaneum) and Japanese beetle larvae (Popillia japonica)
07/31/2003US20030144187 Comprising an osteoprotegerin polypeptide and an immunoglobulin FC region; treatment of bone disorders
07/31/2003US20030144180 Contains as active ingredient a therapeutically effective amount of agent for either enhancing protein kinase c production and/or activation
07/31/2003US20030144127 Providing starting support matrix that has pendent unsaturated groups, subjecting matrix to electron beam or gamma-ray irradiation for the production of a cross-linked support matrix in form of a porous monolith or particles
07/31/2003US20030143739 Composition of restricted cancer cells which produce cancer cell proliferation suppressive materials, and uses thereof
07/31/2003US20030143737 Long-term cell-culture compositions and genetically modified animals derived therefrom
07/31/2003US20030143736 Human feeder cell layer of human adult, fetal or embryonic cells are used as support
07/31/2003US20030143735 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it
07/31/2003US20030143733 Tetrapeptide
07/31/2003US20030143732 RNA interference mediated inhibition of adenosine A1 receptor (ADORA1) gene expression using short interfering RNA
07/31/2003US20030143715 Glutaryl cephalosporin amidase from pseudomonas diminuta BS-203
07/31/2003US20030143711 Hydrolyses organophosphate insecticides including malathion; bioremediation
07/31/2003US20030143710 Protein corresponding to recombinant fungal epoxide hydrolase; use making enantiomerically pure diols and/or epoxides
07/31/2003US20030143709 Used to control expression of a transgene, detect glucuronides in a sample, and isolate glucuronides from a sample
07/31/2003US20030143707 Proteins having DNA repair promoting activity
07/31/2003US20030143693 Growing, under suitable conditions, procaryotic or eucaryotic host cells transformed or transfected with a specific DNA, and isolating the desired polypeptide product of the expression of such DNA sequence
07/31/2003US20030143692 Methods and compositions for modulating integrin-mediated cell-cell interactions
07/31/2003US20030143690 Peptides and proteins that effect protein phosphorylation; genetic engineered DNA; useful for therapy and diagnosis
07/31/2003US20030143688 Human skeletal muscle-specific ubiquitin-conjugating enzyme
07/31/2003US20030143687 Biologic variability of asthma associated factors useful in treating and diagnosing atopic allergies including asthma and related disorders
07/31/2003US20030143685 Nucleic acid expression control sequence cassettes comprising a stable bacteriophage T5 promoter and nucleic acid regulatory sequences, useful for generating stable expressin vectors of high-level protein expression; culture product
07/31/2003US20030143684 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex
07/31/2003US20030143683 Introducing a nucleotide sequence encoding prefered amino acid sequences in into a host cell and culturing the host cell in which the peptides are expressed from the nucleotide sequence; human therapeutics and diagnostic protein
07/31/2003US20030143679 Genes encoding insect odorant receptors and uses thereof
07/31/2003US20030143677 Activated rec-D-hydantoinases
07/31/2003US20030143674 Polypeptides fused to heterologous polypeptide sequences, and an antibodies which bind to the above polypeptides